img

Global Radiation Toxicity Therapeutics Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Radiation Toxicity Therapeutics Market Insights, Forecast to 2034

Treatment of acute radiation syndrome is generally supportive care. This may include blood transfusions, antibiotics, colony-stimulating factors, or stem cell transplant. If radioactive material remains on the skin or in the stomach it should be removed.
Market Analysis and InsightsGlobal Radiation Toxicity Therapeutics Market
Global Radiation Toxicity Therapeutics market is expected to reach to US$ 3987 million in 2024, with a positive growth of %, compared with US$ 3762 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Radiation Toxicity Therapeutics industry is evaluated to reach US$ 5591.9 million in 2029. The CAGR will be 5.8% during 2024 to 2029.
The radiation toxicity treatment market is driven by the increasing use of radiation therapy in cancer treatment and the growing number of nuclear accidents and incidents. Radiation therapy is a critical component in cancer treatment, but it can lead to radiation toxicity, causing various side effects in patients. As the number of cancer cases rises, the demand for radiation therapy is also increasing, consequently driving the need for effective radiation toxicity treatments. Additionally, nuclear accidents and incidents, such as nuclear power plant disasters and radiation exposure from accidents or terrorism, highlight the importance of developing treatments for radiation toxicity. However, the challenge lies in developing treatments that effectively mitigate the harmful effects of radiation while minimizing side effects. Additionally, regulatory approvals and safety concerns are significant challenges in bringing radiation toxicity treatments to the market. Collaborative research efforts and advancements in medical technology are vital in addressing these challenges and providing safer and more effective radiation toxicity treatments.
Report Covers
This report presents an overview of global Radiation Toxicity Therapeutics market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Radiation Toxicity Therapeutics market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Amgen
Partner Therapeutics
Novartis
Viatris
Coherus BioSciences
Jubilant Life Sciences
Siegfried Holdings
Recipharm AB
Mission Pharmacal Company
Segment by Type
Ionizing Radiation
Non-ionizing Radiation

Segment by Application


Hospital
Research & Academic Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Radiation Toxicity Therapeutics introduction, etc. Radiation Toxicity Therapeutics Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Radiation Toxicity Therapeutics
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Radiation Toxicity Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Ionizing Radiation
1.2.3 Non-ionizing Radiation
1.3 Market by Application
1.3.1 Global Radiation Toxicity Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Research & Academic Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Radiation Toxicity Therapeutics Market Perspective (2018-2029)
2.2 Global Radiation Toxicity Therapeutics Growth Trends by Region
2.2.1 Radiation Toxicity Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Radiation Toxicity Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 Radiation Toxicity Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 Radiation Toxicity Therapeutics Market Dynamics
2.3.1 Radiation Toxicity Therapeutics Industry Trends
2.3.2 Radiation Toxicity Therapeutics Market Drivers
2.3.3 Radiation Toxicity Therapeutics Market Challenges
2.3.4 Radiation Toxicity Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Radiation Toxicity Therapeutics by Players
3.1.1 Global Radiation Toxicity Therapeutics Revenue by Players (2018-2024)
3.1.2 Global Radiation Toxicity Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global Radiation Toxicity Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Radiation Toxicity Therapeutics, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Radiation Toxicity Therapeutics Market Concentration Ratio
3.4.1 Global Radiation Toxicity Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Radiation Toxicity Therapeutics Revenue in 2022
3.5 Global Key Players of Radiation Toxicity Therapeutics Head office and Area Served
3.6 Global Key Players of Radiation Toxicity Therapeutics, Product and Application
3.7 Global Key Players of Radiation Toxicity Therapeutics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Radiation Toxicity Therapeutics Breakdown Data by Type
4.1 Global Radiation Toxicity Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global Radiation Toxicity Therapeutics Forecasted Market Size by Type (2024-2029)
5 Radiation Toxicity Therapeutics Breakdown Data by Application
5.1 Global Radiation Toxicity Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global Radiation Toxicity Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Radiation Toxicity Therapeutics Market Size (2018-2029)
6.2 North America Radiation Toxicity Therapeutics Market Size by Type
6.2.1 North America Radiation Toxicity Therapeutics Market Size by Type (2018-2024)
6.2.2 North America Radiation Toxicity Therapeutics Market Size by Type (2024-2029)
6.2.3 North America Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
6.3 North America Radiation Toxicity Therapeutics Market Size by Application
6.3.1 North America Radiation Toxicity Therapeutics Market Size by Application (2018-2024)
6.3.2 North America Radiation Toxicity Therapeutics Market Size by Application (2024-2029)
6.3.3 North America Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
6.4 North America Radiation Toxicity Therapeutics Market Size by Country
6.4.1 North America Radiation Toxicity Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Radiation Toxicity Therapeutics Market Size by Country (2018-2024)
6.4.3 North America Radiation Toxicity Therapeutics Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Radiation Toxicity Therapeutics Market Size (2018-2029)
7.2 Europe Radiation Toxicity Therapeutics Market Size by Type
7.2.1 Europe Radiation Toxicity Therapeutics Market Size by Type (2018-2024)
7.2.2 Europe Radiation Toxicity Therapeutics Market Size by Type (2024-2029)
7.2.3 Europe Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
7.3 Europe Radiation Toxicity Therapeutics Market Size by Application
7.3.1 Europe Radiation Toxicity Therapeutics Market Size by Application (2018-2024)
7.3.2 Europe Radiation Toxicity Therapeutics Market Size by Application (2024-2029)
7.3.3 Europe Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
7.4 Europe Radiation Toxicity Therapeutics Market Size by Country
7.4.1 Europe Radiation Toxicity Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Radiation Toxicity Therapeutics Market Size by Country (2018-2024)
7.4.3 Europe Radiation Toxicity Therapeutics Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Radiation Toxicity Therapeutics Market Size (2018-2029)
8.2 China Radiation Toxicity Therapeutics Market Size by Type
8.2.1 China Radiation Toxicity Therapeutics Market Size by Type (2018-2024)
8.2.2 China Radiation Toxicity Therapeutics Market Size by Type (2024-2029)
8.2.3 China Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
8.3 China Radiation Toxicity Therapeutics Market Size by Application
8.3.1 China Radiation Toxicity Therapeutics Market Size by Application (2018-2024)
8.3.2 China Radiation Toxicity Therapeutics Market Size by Application (2024-2029)
8.3.3 China Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Radiation Toxicity Therapeutics Market Size (2018-2029)
9.2 Asia Radiation Toxicity Therapeutics Market Size by Type
9.2.1 Asia Radiation Toxicity Therapeutics Market Size by Type (2018-2024)
9.2.2 Asia Radiation Toxicity Therapeutics Market Size by Type (2024-2029)
9.2.3 Asia Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
9.3 Asia Radiation Toxicity Therapeutics Market Size by Application
9.3.1 Asia Radiation Toxicity Therapeutics Market Size by Application (2018-2024)
9.3.2 Asia Radiation Toxicity Therapeutics Market Size by Application (2024-2029)
9.3.3 Asia Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
9.4 Asia Radiation Toxicity Therapeutics Market Size by Region
9.4.1 Asia Radiation Toxicity Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Radiation Toxicity Therapeutics Market Size by Region (2018-2024)
9.4.3 Asia Radiation Toxicity Therapeutics Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Type
10.2.1 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Application
10.3.1 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Country
10.4.1 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amgen
11.1.1 Amgen Company Details
11.1.2 Amgen Business Overview
11.1.3 Amgen Radiation Toxicity Therapeutics Introduction
11.1.4 Amgen Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.1.5 Amgen Recent Developments
11.2 Partner Therapeutics
11.2.1 Partner Therapeutics Company Details
11.2.2 Partner Therapeutics Business Overview
11.2.3 Partner Therapeutics Radiation Toxicity Therapeutics Introduction
11.2.4 Partner Therapeutics Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.2.5 Partner Therapeutics Recent Developments
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Radiation Toxicity Therapeutics Introduction
11.3.4 Novartis Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.3.5 Novartis Recent Developments
11.4 Viatris
11.4.1 Viatris Company Details
11.4.2 Viatris Business Overview
11.4.3 Viatris Radiation Toxicity Therapeutics Introduction
11.4.4 Viatris Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.4.5 Viatris Recent Developments
11.5 Coherus BioSciences
11.5.1 Coherus BioSciences Company Details
11.5.2 Coherus BioSciences Business Overview
11.5.3 Coherus BioSciences Radiation Toxicity Therapeutics Introduction
11.5.4 Coherus BioSciences Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.5.5 Coherus BioSciences Recent Developments
11.6 Jubilant Life Sciences
11.6.1 Jubilant Life Sciences Company Details
11.6.2 Jubilant Life Sciences Business Overview
11.6.3 Jubilant Life Sciences Radiation Toxicity Therapeutics Introduction
11.6.4 Jubilant Life Sciences Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.6.5 Jubilant Life Sciences Recent Developments
11.7 Siegfried Holdings
11.7.1 Siegfried Holdings Company Details
11.7.2 Siegfried Holdings Business Overview
11.7.3 Siegfried Holdings Radiation Toxicity Therapeutics Introduction
11.7.4 Siegfried Holdings Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.7.5 Siegfried Holdings Recent Developments
11.8 Recipharm AB
11.8.1 Recipharm AB Company Details
11.8.2 Recipharm AB Business Overview
11.8.3 Recipharm AB Radiation Toxicity Therapeutics Introduction
11.8.4 Recipharm AB Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.8.5 Recipharm AB Recent Developments
11.9 Mission Pharmacal Company
11.9.1 Mission Pharmacal Company Company Details
11.9.2 Mission Pharmacal Company Business Overview
11.9.3 Mission Pharmacal Company Radiation Toxicity Therapeutics Introduction
11.9.4 Mission Pharmacal Company Revenue in Radiation Toxicity Therapeutics Business (2018-2024)
11.9.5 Mission Pharmacal Company Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Radiation Toxicity Therapeutics Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Ionizing Radiation
Table 3. Key Players of Non-ionizing Radiation
Table 4. Global Radiation Toxicity Therapeutics Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Radiation Toxicity Therapeutics Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Radiation Toxicity Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Radiation Toxicity Therapeutics Market Share by Region (2018-2024)
Table 8. Global Radiation Toxicity Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Radiation Toxicity Therapeutics Market Share by Region (2024-2029)
Table 10. Radiation Toxicity Therapeutics Market Trends
Table 11. Radiation Toxicity Therapeutics Market Drivers
Table 12. Radiation Toxicity Therapeutics Market Challenges
Table 13. Radiation Toxicity Therapeutics Market Restraints
Table 14. Global Radiation Toxicity Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Radiation Toxicity Therapeutics Revenue Share by Players (2018-2024)
Table 16. Global Top Radiation Toxicity Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Toxicity Therapeutics as of 2022)
Table 17. Global Radiation Toxicity Therapeutics Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Radiation Toxicity Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Radiation Toxicity Therapeutics, Headquarters and Area Served
Table 20. Global Key Players of Radiation Toxicity Therapeutics, Product and Application
Table 21. Global Key Players of Radiation Toxicity Therapeutics, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Radiation Toxicity Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Radiation Toxicity Therapeutics Revenue Market Share by Type (2018-2024)
Table 25. Global Radiation Toxicity Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Radiation Toxicity Therapeutics Revenue Market Share by Type (2024-2029)
Table 27. Global Radiation Toxicity Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Radiation Toxicity Therapeutics Revenue Share by Application (2018-2024)
Table 29. Global Radiation Toxicity Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Radiation Toxicity Therapeutics Revenue Share by Application (2024-2029)
Table 31. North America Radiation Toxicity Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Radiation Toxicity Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Radiation Toxicity Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Radiation Toxicity Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Radiation Toxicity Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Radiation Toxicity Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Radiation Toxicity Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Radiation Toxicity Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Radiation Toxicity Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Radiation Toxicity Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Radiation Toxicity Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Radiation Toxicity Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Radiation Toxicity Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Radiation Toxicity Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Radiation Toxicity Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Radiation Toxicity Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Radiation Toxicity Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Radiation Toxicity Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Radiation Toxicity Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Radiation Toxicity Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Radiation Toxicity Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Radiation Toxicity Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Radiation Toxicity Therapeutics Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Radiation Toxicity Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Radiation Toxicity Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 63. Amgen Company Details
Table 64. Amgen Business Overview
Table 65. Amgen Radiation Toxicity Therapeutics Product
Table 66. Amgen Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 67. Amgen Recent Developments
Table 68. Partner Therapeutics Company Details
Table 69. Partner Therapeutics Business Overview
Table 70. Partner Therapeutics Radiation Toxicity Therapeutics Product
Table 71. Partner Therapeutics Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 72. Partner Therapeutics Recent Developments
Table 73. Novartis Company Details
Table 74. Novartis Business Overview
Table 75. Novartis Radiation Toxicity Therapeutics Product
Table 76. Novartis Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 77. Novartis Recent Developments
Table 78. Viatris Company Details
Table 79. Viatris Business Overview
Table 80. Viatris Radiation Toxicity Therapeutics Product
Table 81. Viatris Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 82. Viatris Recent Developments
Table 83. Coherus BioSciences Company Details
Table 84. Coherus BioSciences Business Overview
Table 85. Coherus BioSciences Radiation Toxicity Therapeutics Product
Table 86. Coherus BioSciences Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 87. Coherus BioSciences Recent Developments
Table 88. Jubilant Life Sciences Company Details
Table 89. Jubilant Life Sciences Business Overview
Table 90. Jubilant Life Sciences Radiation Toxicity Therapeutics Product
Table 91. Jubilant Life Sciences Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 92. Jubilant Life Sciences Recent Developments
Table 93. Siegfried Holdings Company Details
Table 94. Siegfried Holdings Business Overview
Table 95. Siegfried Holdings Radiation Toxicity Therapeutics Product
Table 96. Siegfried Holdings Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 97. Siegfried Holdings Recent Developments
Table 98. Recipharm AB Company Details
Table 99. Recipharm AB Business Overview
Table 100. Recipharm AB Radiation Toxicity Therapeutics Product
Table 101. Recipharm AB Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 102. Recipharm AB Recent Developments
Table 103. Mission Pharmacal Company Company Details
Table 104. Mission Pharmacal Company Business Overview
Table 105. Mission Pharmacal Company Radiation Toxicity Therapeutics Product
Table 106. Mission Pharmacal Company Revenue in Radiation Toxicity Therapeutics Business (2018-2024) & (US$ Million)
Table 107. Mission Pharmacal Company Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radiation Toxicity Therapeutics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Radiation Toxicity Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Ionizing Radiation Features
Figure 4. Non-ionizing Radiation Features
Figure 5. Global Radiation Toxicity Therapeutics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Radiation Toxicity Therapeutics Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Research & Academic Institutes Case Studies
Figure 9. Radiation Toxicity Therapeutics Report Years Considered
Figure 10. Global Radiation Toxicity Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Radiation Toxicity Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Radiation Toxicity Therapeutics Market Share by Region: 2022 VS 2029
Figure 13. Global Radiation Toxicity Therapeutics Market Share by Players in 2022
Figure 14. Global Top Radiation Toxicity Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiation Toxicity Therapeutics as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Radiation Toxicity Therapeutics Revenue in 2022
Figure 16. North America Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
Figure 18. North America Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
Figure 19. North America Radiation Toxicity Therapeutics Market Share by Country (2018-2029)
Figure 20. United States Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Canada Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Radiation Toxicity Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 23. Europe Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
Figure 24. Europe Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
Figure 25. Europe Radiation Toxicity Therapeutics Market Share by Country (2018-2029)
Figure 26. Germany Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. France Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. U.K. Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Italy Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Russia Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Nordic Countries Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. China Radiation Toxicity Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 33. China Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
Figure 34. China Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
Figure 35. Asia Radiation Toxicity Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 36. Asia Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
Figure 37. Asia Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
Figure 38. Asia Radiation Toxicity Therapeutics Market Share by Region (2018-2029)
Figure 39. Japan Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. South Korea Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. China Taiwan Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Southeast Asia Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. India Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Australia Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Size YoY (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Share by Type (2018-2029)
Figure 47. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Share by Application (2018-2029)
Figure 48. Middle East, Africa, and Latin America Radiation Toxicity Therapeutics Market Share by Country (2018-2029)
Figure 49. Brazil Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Mexico Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Turkey Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Israel Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. GCC Countries Radiation Toxicity Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Amgen Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 56. Partner Therapeutics Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 57. Novartis Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 58. Viatris Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 59. Coherus BioSciences Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 60. Jubilant Life Sciences Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 61. Siegfried Holdings Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 62. Recipharm AB Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 63. Mission Pharmacal Company Revenue Growth Rate in Radiation Toxicity Therapeutics Business (2018-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed